Company intelligence / Profile preview

Ameritek

Seattle area, Washington, United Statesmyameritek.com ↗

Ownership: Private
Employees: ~55
Development stage: Other

Overview

Ameritek develops and manufactures over 160 rapid point-of-care test kits and ELISA laboratory kits for a wide range of human health conditions. Their products are FDA licensed as medical devices and distributed globally to clinical laboratories and healthcare providers. No specific clinical trial results reported—products are commercial diagnostics.

Therapeutic areas: Women's HealthInfectious Diseases
Modalities: In-vitro immunodiagnostics (rapid test kits)ELISA kits
Industry: Protein Biomarker Diagnostics

Beyond the preview

Go deeper on Ameritek.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ameritek.

Explore the full profile